Syndax Pharmaceuticals, Inc. (SNDX)
19.55
-0.43
(-2.15%)
USD |
NASDAQ |
Dec 09, 14:43
Syndax Pharmaceuticals EPS Diluted (Quarterly): -0.7009 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Arcutis Biotherapeutics, Inc. | 0.0558 |
| ACADIA Pharmaceuticals, Inc. | 0.4206 |
| Verastem, Inc. | -1.347 |
| Puma Biotechnology, Inc. | 0.1736 |
| Krystal Biotech, Inc. | 2.660 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -60.72M |
| Revenue (Quarterly) | 45.87M |
| Total Expenses (Quarterly) | 106.59M |
| Enterprise Value | 1.646B |
| Gross Profit Margin (Quarterly) | 95.42% |
| Profit Margin (Quarterly) | -132.4% |
| Earnings Yield | -18.49% |
| Normalized Earnings Yield | -18.49 |